Japan’s cost-effectiveness assessment (CEA) panel has approved a revised handling policy for the CEA system for FY2026, with the health…
HOME > ARCHIVE
ARCHIVE
- WORLD NEWS
June 24, 2002
- REGULATORY NEWS IN BRIEF
June 24, 2002
- BULLETIN
June 24, 2002
- MPC to Place Top Priority on Independent Marketing in US
June 24, 2002
- CORPORATE ROUNDUP NEWS IN BRIEF
June 24, 2002
- Tsumura Forecasts Rapid Recovery of Business
June 24, 2002
- RESEARCH AND DEVELOPMENT NEWS IN BRIEF
June 24, 2002
- Sankyo to Conduct Research with Tularik on GPCR Drug Discovery
June 24, 2002
- Ain Pharmaciez Ties Up with Nice Drug of Nagoya
June 24, 2002
- GSK Strengthening Alliance Strategy in Japan
June 24, 2002
- Korosho Urges National Hospitals to Use More Generics
June 24, 2002
- Toho to Exchange Business with 3 Local Wholesalers
June 24, 2002
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
June 24, 2002
- Univ. of Tokyo Introduces SNP Typing System from Olympus
June 24, 2002
- Matsumotokiyoshi to Restart Aggressive Store Opening
June 24, 2002
- Nissui: Sales, Profits Down Due to Slump of Diagnostics
June 17, 2002
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
June 17, 2002
- Fondaparinux Prevents VTE after Hip Replacement Surgery
June 17, 2002
- Morishita Jintan: 15.6% Drop in Sales, Net Loss of \953 Mil.
June 17, 2002
- JSC to Draft Manual for Antibacterial Clinical Trials in Specific Disease States
June 17, 2002
ページ
The launch of Elevidys has opened the door to gene therapy for DMD, but research into new treatments is already…
I recently sat down with one of the leading medical directors in Japan to discuss the critical evolution of the medical science liaison (MSL) role.The MSL has transformed from a scientific resource into a strategic partner essential for successful product…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…